October 25, 2014 3:54 PM ET

Pharmaceuticals

Company Overview of PT Novartis Indonesia

Company Overview

PT Novartis Indonesia engages in the discovery, development, manufacture, and marketing of pharmaceutical and consumer health products. The company focuses on developing drugs for tropical diseases, such as dengue, tuberculosis, and malaria. PT Novartis Indonesia was formerly known as PT Novartis Biochemie and changed its name to PT Novartis Indonesia in 2006. The company was founded in 1968 and is based in Jakarta, Indonesia. PT Novartis Indonesia operates as a subsidiary of Novartis AG.

AXA Tower 25th-26th Floor

Jl. Prof. Dr. Satrio Kav. 18 Kuningan City

Setiabudi Jakarta Selatan

Jakarta,  12940

Indonesia

Founded in 1968

Key Executives for PT Novartis Indonesia

President Director
Compensation as of Fiscal Year 2014.

Similar Private Companies By Industry

Company Name Region
PT Soho Global Healthcare Asia
PT Sierad Biotek Asia
PT Aventis Pharma (Indonesia) Asia
PT. Novell Pharmaceutical Laboratories Asia
PT CIBA Vision Batam Asia

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Bertelsmann AG Europe
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact PT Novartis Indonesia, please visit www.id.novartis.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.